Add to ORKGCytomegalovirus (CMV) infection takes an important place as a major cause of morbidity and mortality after hematopoietic stem cell transplantation. There have been significant advances in understanding the pathogenesis of CMV, early detection of virus by modern laboratory technics, and conformable antiviral treatment. In this work, determination of high risk stem cell recipients for CMV infection and prophylactic (from the onset of engraftment until 100 days after transplantation) or preemptive (prevention of CMV disease after detection of CMV infection) treatment are reviewed in the context of important literature on this subject
Cytomegalovirus (CMV) remains a major cause of morbidity and mortality in allogeneic hematopoietic s...
Human cytomegalovirus (CMV) represents the most common viral infection after hematopoietic stem cell...
Cytomegalovirus (CMV) remains a major cause of morbidity and mortality in allogeneic hematopoietic s...
Cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT) is one of the c...
AbstractCytomegalovirus (CMV) infection is a major cause of morbidity and mortality after hematopoie...
Cytomegalovirus infection is a frequent complication after transplantation. This infection occurs du...
Cytomegalovirus infection is a frequent complication after transplantation. This infection occurs du...
Prevention of cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT) g...
Cytomegalovirus (HCMV) is a ubiquitous human -herpesvirus highly prevalent in the population. HCMV i...
Cytomegalovirus (HCMV) is a ubiquitous human -herpesvirus highly prevalent in the population. HCMV i...
Since the start of treatment with allogeneic haematopoietic stem cell transplantation (SCT), cytomeg...
Cytomegalovirus (CMV) infection continues to be a problem in selected populations following hemato-p...
Cytomegalovirus is related to high rates of morbidity and mortality after hematopoietic stem cell tr...
This study was performed to evaluate the incidence, risk factors, and outcome of cytomegalovirus (CM...
Cytomegalovirus (CMV) remains a major cause of morbidity and mortality in allogeneic hematopoietic s...
Cytomegalovirus (CMV) remains a major cause of morbidity and mortality in allogeneic hematopoietic s...
Human cytomegalovirus (CMV) represents the most common viral infection after hematopoietic stem cell...
Cytomegalovirus (CMV) remains a major cause of morbidity and mortality in allogeneic hematopoietic s...
Cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT) is one of the c...
AbstractCytomegalovirus (CMV) infection is a major cause of morbidity and mortality after hematopoie...
Cytomegalovirus infection is a frequent complication after transplantation. This infection occurs du...
Cytomegalovirus infection is a frequent complication after transplantation. This infection occurs du...
Prevention of cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT) g...
Cytomegalovirus (HCMV) is a ubiquitous human -herpesvirus highly prevalent in the population. HCMV i...
Cytomegalovirus (HCMV) is a ubiquitous human -herpesvirus highly prevalent in the population. HCMV i...
Since the start of treatment with allogeneic haematopoietic stem cell transplantation (SCT), cytomeg...
Cytomegalovirus (CMV) infection continues to be a problem in selected populations following hemato-p...
Cytomegalovirus is related to high rates of morbidity and mortality after hematopoietic stem cell tr...
This study was performed to evaluate the incidence, risk factors, and outcome of cytomegalovirus (CM...
Cytomegalovirus (CMV) remains a major cause of morbidity and mortality in allogeneic hematopoietic s...
Cytomegalovirus (CMV) remains a major cause of morbidity and mortality in allogeneic hematopoietic s...
Human cytomegalovirus (CMV) represents the most common viral infection after hematopoietic stem cell...
Cytomegalovirus (CMV) remains a major cause of morbidity and mortality in allogeneic hematopoietic s...